Related Experiment Video
Updated: Oct 22, 2025

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Purinergic Signaling in Liver Pathophysiology
Shanu Jain1, Kenneth A Jacobson1
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, United States.
Purinergic receptors, including adenosine, P2Y, and P2X types, are crucial for liver health and disease. Targeting these receptors offers potential therapies for liver pathologies like NAFLD and HCC.
Area of Science:
- Hepatology and Molecular Medicine
- Purinergic Signaling Pathways
Background:
- Extracellular nucleosides and nucleotides activate purinergic receptors (GPCRs and ion channels) in liver cells.
- These receptors regulate normal hepatic metabolic processes and serve as danger signals in disease.
Purpose of the Study:
- To review the role of purinergic signaling in liver health and disease.
- To discuss therapeutic strategies targeting purinergic receptors for liver pathologies.
Main Methods:
- Literature review of studies on purinergic signaling in liver resident cells.
- Analysis of purinergic receptor involvement in hepatic metabolic regulation and disease development.
Main Results:
- Purinergic receptors are vital for normal liver function, regulating metabolism and insulin responsiveness.
- Dysregulated purinergic signaling contributes to non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), fibrosis, hepatocellular carcinoma (HCC), and liver inflammation.
Conclusions:
- Purinergic signaling is a key player in liver homeostasis and pathology.
- Targeting adenosine, P2Y, and P2X receptors presents a promising therapeutic avenue for liver diseases.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cell Specific Gene Expression

